In late September, Aegros employees received a memo asking them to ensure their personal email addresses were up-to-date in the work system because they were about to lose access to their corporate accounts.

At most companies, this would come as a surprise. But Aegros, a blood plasma start-up hoping to rival ASX-listed giant CSL, had struggled to make payroll on time for much of the year. This was just another irritation.